Search company, investor...

Founded Year

2009

Stage

Series D | Alive

Total Raised

$82.38M

Last Raised

$56.11M | 3 yrs ago

About ELEX

ELEX specializes in providing cybersecurity training ranges and industrial control system protection solutions, as well as data forensics and risk assessment tools. The company offers a suite of products designed to enhance cybersecurity training, protect critical infrastructure, and support confidentiality security checks. ELEX's offerings cater to various sectors including military, energy, government, education, and smart manufacturing, providing tailored solutions to meet the specific needs of these industries. ELEX was formerly known as 博智软件. It was founded in 2009 and is based in Nanjing, Jiangsu.

Headquarters Location

4-5/F, Building C, 168 Software Ave. Yuhuatai District

Nanjing, Jiangsu, 210012,

China

(+86) 025-8673 8863

Loading...

Loading...

Expert Collections containing ELEX

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ELEX is included in 1 Expert Collection, including Cybersecurity.

C

Cybersecurity

8,428 items

These companies protect organizations from digital threats.

ELEX Patents

ELEX has filed 1 patent.

The 3 most popular patent topics include:

  • amines
  • calcium channel blockers
  • cardiac arrhythmia
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/28/2019

8/30/2022

Cardiac arrhythmia, Ion channels, Calcium channel blockers, Prodrugs, Amines

Grant

Application Date

3/28/2019

Grant Date

8/30/2022

Title

Related Topics

Cardiac arrhythmia, Ion channels, Calcium channel blockers, Prodrugs, Amines

Status

Grant

Latest ELEX News

Embracer’s Gothic and Elex studio Piranha Bytes is reportedly facing closure

Jan 22, 2024

CEO Michael Rüve says the studio is “in a difficult situation” but tells fans not to write it off yet Posted by Piranha Bytes is reportedly facing closure as part of Embracer Group ’s ongoing restructuring efforts. According to local media reports (via RPG Site ), the German studio behind the Gothic, Risen and Elex series will close its doors unless it can find a new owner or publishing publisher. THQ Nordic , the Embracer operating group that houses the studio, has reportedly said it can keep both the Piranha Bytes name and the rights to the science fantasy-themed RPG series Elex if it can find a way to continue. Piranha Bytes addressed reports about the studio’s potential closure in a message published on X on Monday. “Dear fans, yes, it’s true. We, Piranha Bytes, are in a difficult situation,” it wrote. “There are a lot of news about us circulating right now and this is our answer: Don’t write us off yet! “We do everything to continue creating worlds in which you can lose yourself. This is what our hearts have always beaten for. We are convinced that we will succeed. We are creative minds and there’s no lack of ideas! We stick together, no matter what. “Now, we are focussing on this goal with all our strength and do whatever it takes to find a partner for this project. As soon as there are any news, we will share them with you. Thank you very much for your continuous support.” Embracer announced last June that it was implementing a restructuring programme which would involve the closure of studios, layoffs and the cancellation of some projects.

ELEX Frequently Asked Questions (FAQ)

  • When was ELEX founded?

    ELEX was founded in 2009.

  • Where is ELEX's headquarters?

    ELEX's headquarters is located at 4-5/F, Building C, 168 Software Ave., Nanjing.

  • What is ELEX's latest funding round?

    ELEX's latest funding round is Series D.

  • How much did ELEX raise?

    ELEX raised a total of $82.38M.

  • Who are the investors of ELEX?

    Investors of ELEX include Taizhou Financial Investment Group, Jinquandu, Qingyan Capital, Shanghai Hengji Puye Assets Management, Sinolink Securities Co. and 15 more.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.